ROCKVILLE, Md. (WJZ) — The U.S. Food and Drug Administration has approved a Maryland company’s potential HIV cure for human trials, the company announced this week.
Rockville-based American Gene Technologies said in a news release it will begin its phase one study at sites in the Baltimore and Washington, D.C. areas.READ MORE: Group Of Parents Protest School Mask Mandate Outside Of County Council Meeting In Harford County More Than 1,000 Students In Quarantine In Anne Arundel County; County Executive Supports Vaccine Mandate For All Students
In November 2019, the company said its single-dose gene therapy has a “high potential” of being effective, describing the treatment as a genetically-modified product made from a person’s own cells that focuses on repairing immune system damage caused by the virus.MORE NEWS: Residents & Business Owners Question The Future Of The Inner Harbor's Gallery Mall
The trial is set to begin next month, and the company hopes to report initial data by the end of 2020.